However, 5 unexpected AEs were encountered as significantly more frequent in GH-treated than in untreated patients: sleep apnea, dyspnea, insomnia, anxiety, and decreased libido (occurrence rates, 2%–6%). This evidence concerns the gene GH1 and Anxiety.